No connection

Search Results

BLND

BEARISH
$2.8 Live
Blend Labs, Inc. · NYSE
Target $4.67 (+67.0%)
$2.5 52W Range $4.49

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$727.29M
P/E
N/A
ROE
-0.5%
Profit margin
-2.5%
Debt/Equity
0.01
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
78%
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite a strong gross margin of 57.53% and a healthy current ratio of 2.54, the company continues to report negative earnings, shrinking revenue, and negative returns across ROE, ROA, and ROIC. Insider selling activity totaling $0.65M over the past six months further signals lack of confidence from management, while the stock trades at a high forward P/E of 26.67 despite unproven earnings sustainability. Although recent quarterly EPS surprises have been volatile and some show improvement, the long-term trend remains weak with a 5-year price decline of 86.6%.

Key Strengths

High gross margin (57.53%) suggests strong pricing power or low cost of sales
Healthy liquidity position with current ratio of 2.54 and quick ratio of 2.03
Low debt/equity ratio (0.01) indicates minimal leverage risk
Recent earnings surprises have shown positive volatility, with several beats in the last year
Forward P/E of 26.67 may reflect growth expectations despite current losses

Key Risks

Piotroski F-Score of 2/9 signals severe financial distress and weak profitability
Negative profit margin (-2.49%) and operating margin (-14.66%) indicate ongoing losses
Revenue growth YoY is negative (-0.70%), showing stagnation in top-line expansion
Insiders have been net sellers with $0.65M in sales and zero buys over the last 6 months
Price/book ratio of -58.33 reflects negative book value, raising solvency concerns

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
26
Weak
Value
28
Future
45
Past
30
Health
25
Dividend
0
AI Verdict
High-risk speculative position with weak fundamentals and uncertain recovery path
Key drivers: Low Piotroski F-Score (2/9), Negative profitability metrics, Insider selling pressure, Negative book value and price/book ratio, Volatility in earnings performance
Confidence
75%
Value
28/100

Ref P/E, PEG, Graham Number

Positives
  • Forward P/E of 26.67 could be justified if growth accelerates
Watchpoints
  • Price/Book ratio of -58.33 invalidates traditional value metrics
  • No Graham Number due to unprofitability
  • P/E is N/A due to negative earnings
Future
45/100

Ref Growth rates

Positives
  • Year-over-year EPS growth of +200.0% and Q/Q EPS growth of +150.0% suggest potential turnaround
Watchpoints
  • Revenue growth YoY is negative (-0.70%)
  • No reliable earnings growth trend due to volatility
Past
30/100

Ref Historical trends

Positives
  • Some recent earnings beats with average surprise of 29.32% over last 4 quarters
Watchpoints
  • Long-term price performance is deeply negative (-86.6% over 5Y)
  • History of consistent losses over 19 quarters
  • Earnings surprises highly volatile, including -637.7% miss in 2021
Health
25/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Current ratio of 2.54 and quick ratio of 2.03 support short-term liquidity
Watchpoints
  • Piotroski F-Score of 2/9 indicates critical financial weakness
  • ROE of -0.52%, ROA of -6.24%, and negative ROIC reflect poor capital efficiency
  • Altman Z-Score is unavailable, increasing uncertainty
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend paid (yield N/A)
  • Dividend strength score of 0/100

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$2.8
Analyst Target
$4.67
Upside/Downside
+67.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BLND and closest competitors.

Updated 2026-01-23
BLN
Blend Labs, Inc.
Primary
5Y
-86.6%
3Y
+90.5%
1Y
-24.7%
6M
-22.6%
1M
-7.0%
1W
-5.1%
DJC
Daily Journal Corporation
Peer
5Y
+65.1%
3Y
+81.7%
1Y
+41.0%
6M
+23.1%
1M
-1.0%
1W
+7.7%
LYT
LSI Industries Inc.
Peer
5Y
+147.0%
3Y
+57.7%
1Y
+21.6%
6M
-10.5%
1M
+0.9%
1W
+4.4%
SAB
Sabre Corporation
Peer
5Y
-87.7%
3Y
-52.4%
1Y
-6.9%
6M
+6.2%
1M
+28.6%
1W
+24.3%
NTG
NETGEAR, Inc.
Peer
5Y
-36.8%
3Y
+35.1%
1Y
+10.3%
6M
-28.8%
1M
+13.6%
1W
+1.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
26.67
PEG Ratio
N/A
P/B Ratio
-58.33
P/S Ratio
4.34
EV/Revenue
4.81
EV/EBITDA
-44.95
Market Cap
$727.29M

Profitability

Profit margins and return metrics

Profit Margin -2.49%
Operating Margin -14.66%
Gross Margin 57.53%
ROE -0.52%
ROA -6.24%

Growth

Revenue and earnings growth rates

Revenue Growth -0.7%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.01
Low debt
Current Ratio
2.54
Strong
Quick Ratio
2.03
Excellent
Cash/Share
$0.3

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-26
$N/A
2025-11-06
$0.02
+72.5% surprise
2025-08-07
$-0.04
-230.3% surprise
2025-05-08
$0.01
+245.8% surprise

Technology Sector Comparison

Comparing BLND against 565 companies in the Technology sector (45 bullish, 197 neutral, 323 bearish)
Return on Equity (ROE)
-0.52%
This Stock
vs
-33.47%
Sector Avg
-98.5% (Below Avg)
Profit Margin
-2.49%
This Stock
vs
-11.75%
Sector Avg
-78.8% (Weaker)
Debt to Equity
0.01
This Stock
vs
0.74
Sector Avg
-98.5% (Less Debt)
Revenue Growth
-0.7%
This Stock
vs
4383.21%
Sector Avg
-100.0% (Slower)
Current Ratio
2.54
This Stock
vs
3.59
Sector Avg
-29.2% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

KNEAFSEY BRIAN
Officer
Sell
2026-01-15
25,000 shares · $76,420
TKACH OXANA
Officer
Sell
2026-01-07
2,500 shares · $7,725
KNEAFSEY BRIAN
Officer
Sell
2025-12-15
25,000 shares · $76,485
HAVELI INVESTMENTS, L.P.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-03
1,309,823 shares · $4,068,721
HAVELI INVESTMENTS, L.P.
Director and Beneficial Owner of more than 10% of a Class of Security
Buy
2025-11-26
69,934 shares · $213,850
LING WINNIE
Officer
Stock Award
2025-11-20
31,250 shares
TKACH OXANA
Officer
Stock Award
2025-11-20
37,500 shares
KNEAFSEY BRIAN
Officer
Stock Award
2025-11-20
75,000 shares
GHAMSARI NIMA
Officer and Director
Stock Award
2025-11-20
500,000 shares
HAVELI INVESTMENTS, L.P.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-11-19
1,382,197 shares · $4,193,929
HAVELI INVESTMENTS, L.P.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-11-17
2,154,948 shares · $6,520,685
KNEAFSEY BRIAN
Officer
Sell
2025-11-17
25,000 shares · $74,732
HAVELI INVESTMENTS, L.P.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-11-12
2,255,052 shares · $6,800,328
LING WINNIE
Officer
Sell
2025-10-20
4,000 shares · $14,000
KNEAFSEY BRIAN
Officer
Sell
2025-10-15
25,000 shares · $83,508
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
6 analysts
UBS
2025-11-10
Maintains
Neutral Neutral
Canaccord Genuity
2025-10-28
Maintains
Buy Buy
Canaccord Genuity
2025-08-22
Maintains
Buy Buy
UBS
2025-08-08
Maintains
Neutral Neutral
Keefe, Bruyette & Woods
2025-08-08
Maintains
Market Perform Market Perform

Past News Coverage

Recent headlines mentioning BLND from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile